Skip to content
Screener

Stoke Therapeutics, Inc. STOK Prepaid & Other Current

Prepaid & Other Current at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$327.01M+44.6%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$149.7M-0.4%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$13.55M+16.7%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$13.35M+152%
CalAmp logo
CalAmpCAMP
$2.26M-4.0%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$16.8M+2.0%

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$2.11B+194%
Enterprise value$1.96B+215%
P/S65.8×+62.2×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0.0×
Current ratio+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseCurrent.

The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211874
Line itemMarch 31, 2026December 31, 2025
Cash and cash equivalents$155,659$84,220
Marketable securities - current187,886200,450
Accounts receivable4,4515,936
Prepaid expenses10,1158,736
Interest receivable1,6901,969
Other current assets6,8804,389
Total current assets$366,681$305,700
Marketable securities - long-term67,481106,260

Item 1. Financial Statements.

FAQ

What is Stoke Therapeutics, Inc.'s prepaid & other current?
Stoke Therapeutics, Inc. (STOK) reported prepaid & other current of $10.12M in Q1 2026.
How has Stoke Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Stoke Therapeutics, Inc.'s prepaid & other current decreased by 20.3% year-over-year, from $12.69M to $10.12M.
What is the long-term trend for Stoke Therapeutics, Inc.'s prepaid & other current?
Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s prepaid & other current has grown at a 6.3% compound annual growth rate (CAGR), from $6.44M to $8.74M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Stoke Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude